IDYA
Ideaya Biosciences Inc

1,228
Loading...
Loading...
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
131

Frequently Asked Questions

What is Market Cap of Ideaya Biosciences Inc?
What is the 52-week high for Ideaya Biosciences Inc?
What is the 52-week low for Ideaya Biosciences Inc?
What is Ideaya Biosciences Inc stock price today?
What was Ideaya Biosciences Inc stock price yesterday?
What is the PE ratio of Ideaya Biosciences Inc?
What is the Price-to-Book ratio of Ideaya Biosciences Inc?
What is the 50-day moving average of Ideaya Biosciences Inc?
How many employess does Ideaya Biosciences Inc has?

Latest IDYA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.